Correlation Between Queclink Wireless and Innovative Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Queclink Wireless and Innovative Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Queclink Wireless and Innovative Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Queclink Wireless Solutions and Innovative Medical Management, you can compare the effects of market volatilities on Queclink Wireless and Innovative Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Queclink Wireless with a short position of Innovative Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Queclink Wireless and Innovative Medical.

Diversification Opportunities for Queclink Wireless and Innovative Medical

0.41
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Queclink and Innovative is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Queclink Wireless Solutions and Innovative Medical Management in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovative Medical and Queclink Wireless is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Queclink Wireless Solutions are associated (or correlated) with Innovative Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovative Medical has no effect on the direction of Queclink Wireless i.e., Queclink Wireless and Innovative Medical go up and down completely randomly.

Pair Corralation between Queclink Wireless and Innovative Medical

Assuming the 90 days trading horizon Queclink Wireless Solutions is expected to generate 0.74 times more return on investment than Innovative Medical. However, Queclink Wireless Solutions is 1.34 times less risky than Innovative Medical. It trades about -0.03 of its potential returns per unit of risk. Innovative Medical Management is currently generating about -0.06 per unit of risk. If you would invest  1,455  in Queclink Wireless Solutions on October 7, 2024 and sell it today you would lose (102.00) from holding Queclink Wireless Solutions or give up 7.01% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Queclink Wireless Solutions  vs.  Innovative Medical Management

 Performance 
       Timeline  
Queclink Wireless 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Queclink Wireless Solutions has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Innovative Medical 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Innovative Medical Management are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Innovative Medical may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Queclink Wireless and Innovative Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Queclink Wireless and Innovative Medical

The main advantage of trading using opposite Queclink Wireless and Innovative Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Queclink Wireless position performs unexpectedly, Innovative Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovative Medical will offset losses from the drop in Innovative Medical's long position.
The idea behind Queclink Wireless Solutions and Innovative Medical Management pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance